Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.64 - $8.23 $17,836 - $40,327
4,900 Added 9.16%
58,400 $471,000
Q2 2024

Aug 14, 2024

BUY
$4.08 - $6.39 $218,280 - $341,865
53,500 New
53,500 $231,000
Q2 2023

Aug 23, 2023

SELL
$3.94 - $5.8 $9,456 - $13,920
-2,400 Reduced 12.44%
16,900 $66,000
Q1 2023

May 15, 2023

BUY
$3.22 - $4.61 $19,642 - $28,121
6,100 Added 46.21%
19,300 $80,000
Q4 2022

Feb 14, 2023

SELL
$2.81 - $4.45 $66,878 - $105,910
-23,800 Reduced 64.32%
13,200 $56,000
Q3 2022

Nov 14, 2022

BUY
$2.82 - $7.52 $49,914 - $133,104
17,700 Added 91.71%
37,000 $104,000
Q2 2022

Aug 15, 2022

BUY
$2.73 - $5.61 $6,279 - $12,903
2,300 Added 13.53%
19,300 $69,000
Q1 2022

May 16, 2022

BUY
$3.83 - $6.24 $12,256 - $19,968
3,200 Added 23.19%
17,000 $99,000
Q4 2021

Feb 14, 2022

SELL
$4.47 - $5.56 $41,124 - $51,152
-9,200 Reduced 40.0%
13,800 $65,000
Q2 2021

Aug 06, 2021

BUY
$6.05 - $10.09 $4,840 - $8,072
800 Added 3.6%
23,000 $164,000
Q1 2021

May 14, 2021

BUY
$6.84 - $17.58 $47,880 - $123,059
7,000 Added 46.05%
22,200 $200,000
Q4 2019

Feb 12, 2020

BUY
$4.96 - $7.75 $75,392 - $117,800
15,200 New
15,200 $104,000
Q3 2019

Nov 14, 2019

SELL
$6.38 - $9.69 $206,074 - $312,987
-32,300 Closed
0 $0
Q2 2019

Aug 20, 2019

SELL
$5.93 - $10.57 $31,429 - $56,021
-5,300 Reduced 14.1%
32,300 $290,000
Q1 2019

May 15, 2019

BUY
$6.95 - $13.25 $261,320 - $498,200
37,600 New
37,600 $355,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $334M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.